Search

Author/Creator Moorehead, Lisa

1. A Phase I, Randomized, Placebo-Controlled, 3-Day, Ascending-Dose Study of Gs-9451, An Ns3/4A Protease Inhibitor, in Genotype 1 Hepatitis C Patients. Issue 3 (April 2013)

Authors:
Lawitz, Eric J; Hill, John M; Marbury, Thomas; DeMicco, Michael P; Delaney, William; Yang, Jenny; Moorehead, Lisa; Mathias, Anita; Mo, Hongmei; McHutchison, John G; Rodriguez-Torres, Maribel; Gordon, Stuart C
Journal:
Antiviral therapy
Issue:
Volume 18:Issue 3(2013)
Page Start:
311
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety, Pharmacokinetics and Pharmacodynamics of Gs-9620, An Oral Toll-Like Receptor 7 Agonist. Issue 3 (April 2013)

Authors:
Lopatin, Uri; Wolfgang, Grushenka; Tumas, Daniel; Frey, Christian R; Ohmstede, Carol; Hesselgesser, Joseph; Kearney, Brian; Moorehead, Lisa; Subramanian, G Mani; McHutchison, John G
Journal:
Antiviral therapy
Issue:
Volume 18:Issue 3(2013)
Page Start:
409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search